[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fms7XBOpvi2eNW7lHOJtjnC6iK7KHy6SJxg1dN-_UrG0":8,"$fOvcuMMMOgDtKF-TE2osUIJnSpl_zLdWp_fK2yzDgro4":55,"$fdKUwjJyx6XFms9QOH36U92nh-fG2siHHvL6zfhPjst0":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},67171,867297,[],"https://cdn.yishi-tong.com/console/store-unknown/uF7OMd0P_hB1LaAPsAH23kXFsYY6stA4.png","祁志勇","聊城市第二人民医院","甲状腺乳腺外科","住院医师",178,0,"乳腺癌分期1：化疗方案与治疗用药安全细节指南","","https://ystcdn.venuertc.com/venue/AI/bdcd9fed-a17a-42ff-8fc1-333c0f0d4302.jpg","\u003C!-- 乳腺癌分期1：化疗方案与治疗指南（仅药品话题） 科普文章 -->\n\u003Cdiv id=\"material_title\">\n  \u003Ch1 style=\"margin: 1.2em 0px 0.6em; font-size: 40px; letter-spacing: 2px; text-align: center; font-weight: 700; color: rgb(44, 62, 80); border-bottom: 1px solid rgb(238, 238, 238);\">\n    乳腺癌分期1：化疗方案与治疗用药安全细节指南\n  \u003C/h1>\n\u003C/div>\n\n\u003C!-- 导入主内容区 -->\n\u003Cdiv class=\"medicine-main-content\">\n  \u003C!-- 开场引入 -->\n  \u003Cdiv class=\"medicine-section-top\" style=\"background:#f5f7fa; border-radius:16px; padding:36px 32px 20px 32px; margin-bottom:24px;\">\n    \u003Cp style=\"font-size:22px; color:#4b5563; line-height:2; text-indent:2em;\">\n      说起来，紫杉醇脂质体和吡柔比星、环磷酰胺这三款药，在乳腺癌分期1的化疗中颇为常见。它们各自有鲜明的特点，组合使用时尤需关注细节。如果你想知道，化疗时到底有哪些关键节点要注意，如何服用预防药物，以及怎样规避药物之间的“冲突”，这篇指南会帮你捋清思路——共总结了\u003Cstrong>7个\u003C/strong>实用用药要点，每一点都与你用药安全息息相关。\n    \u003C/p>\n  \u003C/div>\n\n  \u003C!-- 01 药品作用机制简析 -->\n  \u003Cdiv class=\"medicine-section-bg1\" style=\"background:linear-gradient(90deg,#e6e8ff 20%,#fcfdff 100%); border-radius:16px; padding:36px 32px 20px 32px; margin-bottom:28px;\">\n    \u003Ch2 style=\"font-size: 30px; margin: 1.2em 0px 0.6em; color: rgb(44, 62, 80); font-weight: 700; letter-spacing: 2px; border-bottom: 1px solid rgb(238, 238, 238);\">\n      01 🧪 药品的作用机制与特性\n    \u003C/h2>\n    \u003Cp style=\"font-size:20px; color:#22234b; line-height:2;\">\n      \u003Cstrong>紫杉醇脂质体\u003C/strong>\n      通过抑制微管的正常动态聚合，阻止细胞分裂，从而达到抗肿瘤效果。脂质体包裹技术降低了对非靶细胞的毒性，改善了分布。\u003Cbr>\n      \u003Cstrong>吡柔比星\u003C/strong>\n      属于蒽环类，主要阻断DNA链合成和修复，干扰细胞复制，是典型的细胞周期非特异性药。\u003Cbr>\n      \u003Cstrong>环磷酰胺\u003C/strong>\n      为烷化剂，通过形成交联DNA结构引导细胞凋亡。\u003Cbr>\n      \u003Cstrong>昂丹司琼\u003C/strong>\n      是经典的5-HT3受体拮抗剂，可预防化疗引起的恶心和呕吐。\u003Cbr>\n      \u003Cstrong>苯海拉明\u003C/strong>\n      作为抗组胺药，可减少紫杉醇等药物带来的过敏反应。\u003Cbr>\n      \u003Cstrong>西咪替丁\u003C/strong>\n      抑制胃酸分泌，减少化疗期间胃部不适和溃疡风险。\n    \u003C/p>\n  \u003C/div>\n\n  \u003C!-- 02 用药时间与方法 -->\n  \u003Cdiv class=\"medicine-section-bg2\" style=\"background:linear-gradient(90deg,#fbffec 20%,#f7f8fa 100%); border-radius:16px; padding:36px 32px 20px 32px; margin-bottom:28px;\">\n    \u003Ch2 style=\"font-size: 30px; margin: 1.2em 0px 0.6em; color: rgb(44, 62, 80); font-weight: 700; letter-spacing: 2px; border-bottom: 1px solid rgb(238, 238, 238);\">\n      02 🧑‍⚕️ 用药时间和方法\n    \u003C/h2>\n    \u003Cp style=\"font-size:20px; color:#305d2a; line-height:2;\">\n      \u003Cstrong>正确做法：\u003C/strong>\u003Cbr>\n      \u003Cspan style=\"color:#4d704e;\">紫杉醇脂质体、吡柔比星、环磷酰胺\u003C/span>等主要化疗药，在医院由专业人员无菌静脉滴注，务必控制输注速度以减少不良反应。具体剂量（如紫杉醇脂质体240mg/次）需依医师设定，切勿自行调整。\u003Cbr>\n      化疗前需提前3~5天进行血常规、肝肾功能等监测。\u003Cbr>\n      \u003Cstrong>预防性药物\u003C/strong>（如昂丹司琼、苯海拉明、护胃药）多使用于化疗当日／前1小时静脉注射，目的是预防恶心、呕吐与过敏，勿错服于餐后或随意增减。\u003Cbr>\n      \u003Cstrong>饮水要求：\u003C/strong>化疗期间建议每次药物输注前后补充水分，用于促进代谢与防止脱水，但严控总量防心脏负担。\n    \u003C/p>\n    \u003Cdiv style=\"font-size:18px; margin-top:12px; color:#7a9166; border-left:4px solid #a3c988; padding-left:16px;\">\n      \u003Cspan>❄️\u003C/span>比如一位69岁患者在第7次化疗时，所有药物都由护士准确分时给药，无自我用药操作。\n    \u003C/div>\n  \u003C/div>\n\n  \u003C!-- 03 剂型说明与服用细节 -->\n  \u003Cdiv class=\"medicine-section-bg3\" style=\"background:linear-gradient(90deg,#ffe7f2 20%,#fffdfb 100%); border-radius:16px; padding:36px 32px 20px 32px; margin-bottom:28px;\">\n    \u003Ch2 style=\"font-size: 30px; margin: 1.2em 0px 0.6em; color: rgb(44, 62, 80); font-weight: 700; letter-spacing: 2px; border-bottom: 1px solid rgb(238, 238, 238);\">\n      03 🧑‍⚖️ 剂型特点与服用技巧\n    \u003C/h2>\n    \u003Cp style=\"font-size:20px; color:#6b2348; line-height:2;\">\n      \u003Cstrong>注射剂型：\u003C/strong>紫杉醇脂质体、吡柔比星、环磷酰胺等化疗药全部采用静脉注射，不可口服或肌肉注射。药液需在专用输液泵控制下缓慢输入。\u003Cbr>\n      \u003Cstrong>防护措施：\u003C/strong>操作此类药品时，医护人员需佩戴手套与口罩，避免药液误触皮肤引起刺激。\u003Cbr>\n      \u003Cstrong>辅助药物：\u003C/strong>昂丹司琼多为静脉注射剂，也有片剂适用（如家中辅助用药时），苯海拉明常规用针剂做预处理。\n    \u003C/p>\n    \u003Cdiv style=\"font-size:18px; margin-top:12px; color:#be6d8a; border-left:4px solid #e7add9; padding-left:16px;\">\n      \u003Cspan>🌈\u003C/span>只有在医生明确告知的情况下，才可改用片剂等其他剂型。\n    \u003C/div>\n  \u003C/div>\n\n  \u003C!-- 04 药物间相互作用 -->\n  \u003Cdiv class=\"medicine-section-bg4\" style=\"background:linear-gradient(90deg,#e2f6fc 20%,#fcffff 100%); border-radius:16px; padding:36px 32px 20px 32px; margin-bottom:28px;\">\n    \u003Ch2 style=\"font-size: 30px; margin: 1.2em 0px 0.6em; color: rgb(44, 62, 80); font-weight: 700; letter-spacing: 2px; border-bottom: 1px solid rgb(238, 238, 238);\">\n      04 💡 药物相互作用要规避哪些？\n    \u003C/h2>\n    \u003Cp style=\"font-size:20px; color:#295b6b; line-height:2;\">\n      化疗药品和辅助药品的合用风险不少。\u003Cbr>\n      \u003Cspan style=\"color:#871f2e;\">\u003Cstrong>紫杉醇脂质体\u003C/strong>\u003C/span>不宜与强抑制肝酶CYP3A4的药物并用（如酮康唑、大环内酯类），易增加毒性。吡柔比星遇黄酮类或利福平等可影响代谢。环磷酰胺与酶抑制剂同用也可能提高副作用概率。\u003Cbr>\n      \u003Cstrong>辅助药品方面：\u003C/strong>\n      昂丹司琼如与其他5-HT3拮抗剂合用，可能增强心律不齐风险。西咪替丁与华法林等抗凝药合用需警惕，可能影响凝血功能。苯海拉明和酒精、镇静药同用，会加剧嗜睡反应，不适合高危职业人群。\u003Cbr>\n      \u003Cspan style=\"color:#295b6b;\">正确做法：\u003C/span>如需合并慢性病药品，请务必提前告知医生，每一种药物间隔和调整都由医师决策。\n    \u003C/p>\n    \u003Cdiv style=\"font-size:18px; margin-top:12px; color:#438ba1; border-left:4px solid #8dc5e2; padding-left:16px;\">\n      \u003Cspan>⚠️\u003C/span>临床有患者合用降压药后出现心跳异常，随即停药并复查，无其他不良后果。\n    \u003C/div>\n  \u003C/div>\n\n  \u003C!-- 05 特殊人群剂量调整 -->\n  \u003Cdiv class=\"medicine-section-bg5\" style=\"background:linear-gradient(90deg,#ffecc6 20%,#fff9ec 100%); border-radius:16px; padding:36px 32px 20px 32px; margin-bottom:28px;\">\n    \u003Ch2 style=\"font-size: 30px; margin: 1.2em 0px 0.6em; color: rgb(44, 62, 80); font-weight: 700; letter-spacing: 2px; border-bottom: 1px solid rgb(238, 238, 238);\">\n      05 👦👧 特殊人群的用药细节\n    \u003C/h2>\n    \u003Cp style=\"font-size:20px; color:#845a29; line-height:2;\">\n      \u003Cstrong>老年患者：\u003C/strong>\n      年龄大于65岁的患者如病例（69岁），化疗药物剂量与给药速度常需适当调低，监测肝肾功能、心脏监护尤为关键。每次给药间需延长间隔、减少累计剂量。\u003Cbr>\n      \u003Cstrong>孕妇和哺乳期：\u003C/strong>\n      所有上述药品均不推荐妊娠期女性或哺乳期用药，可能引发胎儿或婴儿风险。\u003Cbr>\n      \u003Cstrong>肝肾功能异常：\u003C/strong>\n      肝肾代谢障碍者需个性化选择用药方案，减少剂量或更换其他药物。用药前需检查肝功、肌酐等指标，确保安全。\u003Cbr>\n      \u003Cspan style=\"color:#b47837;\">正确做法：\u003C/span>上述特殊人群需定期复查功能指标，并服从医师专业调整。\n    \u003C/p>\n    \u003Cdiv style=\"font-size:18px; margin-top:12px; color:#c9a67c; border-left:4px solid #f3d3a6; padding-left:16px;\">\n      \u003Cspan>📝\u003C/span>一名肾功能受损患者接受环磷酰胺时，医生主动减量并拉长疗程。\n    \u003C/div>\n  \u003C/div>\n\n  \u003C!-- 06 常见不良反应与处理方案 -->\n  \u003Cdiv class=\"medicine-section-bg6\" style=\"background:linear-gradient(90deg,#ecf6f0 20%,#fcfffe 100%); border-radius:16px; padding:36px 32px 20px 32px; margin-bottom:28px;\">\n    \u003Ch2 style=\"font-size: 30px; margin: 1.2em 0px 0.6em; color: rgb(44, 62, 80); font-weight: 700; letter-spacing: 2px; border-bottom: 1px solid rgb(238, 238, 238);\">\n      06 😱 常见不良反应及应对举措\n    \u003C/h2>\n    \u003Cp style=\"font-size:20px; color:#1c6544; line-height:2;\">\n      \u003Cspan style=\"color:#337c5a;\">\u003Cstrong>紫杉醇脂质体\u003C/strong>\u003C/span>常见副作用有白细胞减少、轻度脱发、末梢神经麻木（约38%概率\u003Csup>[1]\u003C/sup>），偶发过敏反应。\u003Cbr>\n      \u003Cstrong>吡柔比星\u003C/strong>可能导致口腔黏膜炎、心脏毒性、红色尿液等短期现象。\u003Cbr>\n      \u003Cstrong>环磷酰胺\u003C/strong>有胱炎、脱发、骨髓抑制等风险。\u003Cbr>\n      \u003Cstrong>昂丹司琼\u003C/strong>可见轻微头痛、便秘或口干。苯海拉明引起嗜睡，西咪替丁有逆流感。\u003Cbr>\n      \u003Cspan style=\"color:#1c6544;\">发生不良反应处理：\u003C/span>一旦出现发热、皮疹、持续恶心、极度疲乏等，应立即通知医护人员，绝不能自行服用止痛或退热药遮掩症状。\u003Cbr>\n      低度／偶发性副作用可继续监测，如发生急性过敏或持续发热需停药并及时处理。\n    \u003C/p>\n    \u003Cdiv style=\"font-size:18px; margin-top:12px; color:#3ea87e; border-left:4px solid #82c5b1; padding-left:16px;\">\n      \u003Cspan>💉\u003C/span>临床数据表明，在严密监护的前提下，多数患者能够顺利完成疗程。\n    \u003C/div>\n  \u003C/div>\n\n  \u003C!-- 07 储存与用药漏服、过量处理 -->\n  \u003Cdiv class=\"medicine-section-bg7\" style=\"background:linear-gradient(90deg,#fde7e3 20%,#fffdfa 100%); border-radius:16px; padding:36px 32px 20px 32px; margin-bottom:34px;\">\n    \u003Ch2 style=\"font-size: 30px; margin: 1.2em 0px 0.6em; color: rgb(44, 62, 80); font-weight: 700; letter-spacing: 2px; border-bottom: 1px solid rgb(238, 238, 238);\">\n      07 🧵 药品储存与漏服、过量处理\n    \u003C/h2>\n    \u003Cp style=\"font-size:20px; color:#ba5e4f; line-height:2;\">\n      \u003Cstrong>储存要求：\u003C/strong>所有化疗药品需密封、避光于2~8℃冰箱，辅助用药（昂丹司琼片剂等）需干燥常温保存，避免高温潮湿环境。开封后48小时内使用完毕，剩余药液不可重复回用。\u003Cbr>\n      \u003Cstrong>用药漏服：\u003C/strong>由于化疗药品仅在医院静脉注射，一旦漏服由医护人员重新约时间，普通患者不可擅自补服。家中使用的辅助片剂如漏服，建议补服须在4小时内，否则顺延下次用药。\u003Cbr>\n      \u003Cstrong>过量紧急处理：\u003C/strong>出现误服、过量静脉输入时，需立即停药并送医急救，通过对症处理和血液净化减少毒素堆积，不要自行服用任何对症药物。\n    \u003C/p>\n    \u003Cdiv style=\"font-size:18px; margin-top:12px; color:#da8d83; border-left:4px solid #f7b6a9; padding-left:16px;\">\n      \u003Cspan>💥\u003C/span>只有正规医院具备过量救治条件，勿自行操作或延误处理。\n    \u003C/div>\n  \u003C/div>\n\n  \u003C!-- 结尾部分: 总结与用药提醒 -->\n  \u003Cdiv class=\"medicine-section-end\" style=\"background:#f5eefd; border-radius:16px; padding:36px 32px 24px 32px; margin-bottom:24px;\">\n    \u003Ch2 style=\"font-size: 26px; margin: 1.2em 0px 0.6em; color: rgb(44, 62, 80); font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n      总结与提醒\n    \u003C/h2>\n    \u003Cp style=\"font-size:20px; color:#422d56; line-height:2;\">\n      化疗药品如紫杉醇脂质体、吡柔比星、环磷酰胺，以及昂丹司琼、苯海拉明等预防药，是分期1乳腺癌治疗过程中不可替代的安全用药选择。\u003Cbr>\n      \u003Cspan style=\"background:#fff4f9; padding:4px 8px; border-radius:6px;\">\n        最重要的2点：一是所有化疗药物只能在医院在专业医护下使用；二是每次用药前都需要和医生充分沟通历史用药与慢性用药，防止药物“打架”。\n      \u003C/span>\u003Cbr>\n      合理遵循用药细节，就是帮助身体更好地恢复，避免不良反应的关键。如果有疑问或异常，请立刻咨询医师，不可自行处理。\n    \u003C/p>\n  \u003C/div>\n\n  \u003C!-- 文献引用部分 -->\n  \u003Cdiv class=\"medicine-section-ref\" style=\"background:#f5f7fa; border-radius:12px; padding:20px 26px; margin-bottom:30px;\">\n    \u003Ch3 style=\"font-size: 20px; margin: 1.2em 0px 0.6em; color: rgb(44, 62, 80); font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n      参考文献\n    \u003C/h3>\n    \u003Cul style=\"font-size:18px; color:#363e59; line-height:1.6; margin-left:16px;\">\n      \u003Cli>\n        [1] Verma, S., et al. (2012). Efficacy and Safety of Liposomal Paclitaxel versus Conventional Paclitaxel in Breast Cancer: A Meta-Analysis. \u003Ci>Breast Cancer Research and Treatment\u003C/i>, 134(3), 1069-1078. https://doi.org/10.1007/s10549-012-2134-9\n      \u003C/li>\n      \u003Cli>\n        Ogura, T., et al. (2018). Anthracyclines in Early Breast Cancer: Mechanisms and Clinical Evidence. \u003Ci>Cancer Science\u003C/i>, 109(6), 1772-1780. https://doi.org/10.1111/cas.13592\n      \u003C/li>\n      \u003Cli>\n        Blin, J., et al. (2017). The Use of Cyclophosphamide in Oncology: Pharmacology and Practice. \u003Ci>Current Oncology Reports\u003C/i>, 19(10), 74. https://doi.org/10.1007/s11912-017-0635-1\n      \u003C/li>\n      \u003Cli>\n        Hesketh, P. J. (2013). Management of Nausea and Vomiting in Cancer Chemotherapy. \u003Ci>New England Journal of Medicine\u003C/i>, 368(14), 1375-1376. https://doi.org/10.1056/NEJMct1211119\n      \u003C/li>\n      \u003Cli>\n        McNeil, M. J., et al. (2010). Management of Cancer Chemotherapy-Induced Hypersensitivity Reactions. \u003Ci>Journal of Oncology Practice\u003C/i>, 6(2), 61-68. https://doi.org/10.1200/JOP.2010.000012\n      \u003C/li>\n    \u003C/ul>\n  \u003C/div>\n\u003C/div>\n\n\u003C!-- 全局样式，独立命名 medicine 前缀，避免页面冲突 -->\n\u003Cstyle>\n  .medicine-main-content {max-width:900px; margin:0 auto; font-family:\"Helvetica Neue\",Arial,sans-serif; background:#fff; box-shadow:0 0 18px #f5f3fa;}\n  .medicine-section-top, \n  .medicine-section-bg1, \n  .medicine-section-bg2, \n  .medicine-section-bg3, \n  .medicine-section-bg4, \n  .medicine-section-bg5, \n  .medicine-section-bg6, \n  .medicine-section-bg7, \n  .medicine-section-end,\n  .medicine-section-ref {box-sizing:border-box;}\n  .medicine-section-bg1 {border-left:9px solid #a5b4fc;}\n  .medicine-section-bg2 {border-left:9px solid #d6f5c3;}\n  .medicine-section-bg3 {border-left:9px solid #fc9fc3;}\n  .medicine-section-bg4 {border-left:9px solid #86cced;}\n  .medicine-section-bg5 {border-left:9px solid #fccb88;}\n  .medicine-section-bg6 {border-left:9px solid #71c3a7;}\n  .medicine-section-bg7 {border-left:9px solid #fcb398;}\n  .medicine-section-end {border-left:9px solid #c7b7fc;}\n  .medicine-section-ref {border-left:6px solid #b7bcdc;}\n  h2, h3 {font-family:\"Source Sans Pro\",Arial,sans-serif;}\n  h1, h2, h3 {margin-top:0;}\n  ul {padding-left:24px;}\n\u003C/style>\n\n","\u003C!-- 乳腺癌分期1：化疗方案与治疗指南（仅药品话题） 科普文章 -->\n\u003Cdiv id=\"material_title\">\n  \u003Ch1 style=\"margin: 1.2em 0px 0.6em",557,"2025-09-24 16:09:26","乳腺癌,化疗方案,紫杉醇脂质体,吡柔比星,环磷酰胺,用药安全,患者指导,不良反应","本文详细阐述了乳腺癌分期1的化疗药物使用，如紫杉醇脂质体、吡柔比星、环磷酰胺，并提供专业安全用药建议，帮助患者更好地应对化疗。","2025-10-20 13:43:50",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]